These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1057 related articles for article (PubMed ID: 12340192)

  • 1. Comprehensive overview of intrauterine contraceptive device (IUCD).
    Nnatu S
    J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):91-6. PubMed ID: 12340192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper IUDs.
    Thiery M
    Contracept Deliv Syst; 1983 Jul; 4(3):175-85. PubMed ID: 12265360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intrauterine device today.
    Rioux JE
    J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endometrial cytology of IUD smears: endometrial reaction study].
    Salome N; Rezende CD; Peixoto RM; Rocha AH
    J Bras Ginecol; 1986; 96(6):263-6. PubMed ID: 12268684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinolytic activity in endometrium and uterine fluid of women using intrauterine contraceptive devices].
    Lu Q
    Shengzhi Yu Biyun; 1983 Aug; 3(3):6-8. PubMed ID: 12267402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno and histochemical study of endometrium in women using copper IUCD.
    Mousa MA; El-mekkawi TM; Abdel Aziz AA; El-saharty MF
    Popul Sci; 1985; 6():41-50. PubMed ID: 12349093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructure responses of human endometrium to inert and copper IUDs as viewed by scanning electron microscopy.
    El-badrawi HH; Hafez ES; Fayad M; Shafeek A
    Contracept Deliv Syst; 1980 Apr; 1(2):103-11. PubMed ID: 12336235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The intrauterine active disposition in the dysfunctional uterine bleeding: its action on miometrium, endometrium and vaginal epithelium].
    Ruiz-velasco V; Martinez Manatau J; Illanes Amurrio S; Romero Salinas G; Maqueo Topete M; Conde De Varges BI
    J Bras Ginecol; 1974 Oct; 78(4):417-31. PubMed ID: 12278214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
    Kurz KH
    Contracept Deliv Syst; 1981 Jan; 2(1):21-9. PubMed ID: 12278585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of copper-containing intrauterine contraceptive devices (IUCD) on growth of endometrial and cervical cells.
    Amin NS; Al-janabi NY; Banna HB; Al-tai S; Al-kateeb A; Kubba K; Al-nasiri N
    Med Sci Res; 1989 May 1-15; 17(9):433-4. PubMed ID: 12283436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IUD failures--possible mechanisms.
    Barwin BN; Gillieson M
    Contracept Deliv Syst; 1983 Sep; 4(4):311-6. PubMed ID: 12265807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.